Biohope is holding these days meetings in Boston with investors and companies  for future collaborations in the development of the IMMUNOBIOGRAM®, cutting-edge technology in the treatment of chronic inflammatory diseases that will allow the personalization of immunosuppressive therapy, selecting the drugs and the most appropriate doses.

 

> We were in BIO International Convention

 

> We were in RESI Conference